A 72-year-old woman with coronary artery bypass graft surgery (CABG) with mitral valve replacement (MVR) using a 27-mm Carpentier-Edwards bioprosthesis (Edwards Lifesciences, Irvine, California) 6 years earlier was referred to our institution with severe, symptomatic prosthetic valve mitral stenosis. Her clinical history was otherwise significant for recent percutaneous coronary intervention, bilateral renal artery stenting, and cerebrovascular disease with a 90% stenosis of the left internal carotid artery (ICA) and moderate stenosis of the right ICA. Prior CABG/MVR was complicated by sternal wound dehiscence necessitating complex reconstruction. In preparation for surgery, stenting of the left ICA was performed without complication. The patient was then taken to the operative suite for MVR via a right anterior thoracotomy; however, the surgery was aborted because of profound adhesions with obliteration of the pericardial space and patient intolerance to single lung ventilation. Consequently, the patient was brought to the cardiac catheterization laboratory for transcatheter valve-in-valve (VIV) implantation in the mitral position. Transesophageal echocardiography confirmed severe prosthetic valve mitral stenosis 
A 72-year-old woman with coronary artery bypass graft surgery (CABG) with mitral valve replacement (MVR) using a 27-mm Carpentier-Edwards bioprosthesis (Edwards Lifesciences, Irvine, California) 6 years earlier was referred to our institution with severe, symptomatic prosthetic valve mitral stenosis. Her clinical history was otherwise significant for recent percutaneous coronary intervention, bilateral renal artery stenting, and cerebrovascular disease with a 90% stenosis of the left internal carotid artery (ICA) and moderate stenosis of the right ICA. Prior CABG/MVR was complicated by sternal wound dehiscence necessitating complex reconstruction. In preparation for surgery, stenting of the left ICA was performed without complication. The patient was then taken to the operative suite for MVR via a right anterior thoracotomy; however, the surgery was aborted because of profound adhesions with obliteration of the pericardial space and patient intolerance to single lung ventilation. Consequently, the patient was brought to the cardiac catheterization laboratory for transcatheter valve-in-valve (VIV) implantation in the mitral position. Transesophageal echocardiography confirmed severe prosthetic valve mitral stenosis ( Fig. 1, Online Video 1) . A 26-F Ascendra delivery system (Edwards Lifesciences) was placed in the left ventricular apex and then advanced to the left atrium ( Fig. 2A) . A 26-mm Edwards SAPIEN heart valve (Edwards Lifesciences) was carefully positioned within the mitral prosthesis under fluoroscopic and echocardiographic guidance (Figs. 2B and 2C) and slowly deployed during rapid right ventricular pacing and reduced pump flows. Only minimal paravalvular regurgitation was noted at the end of the procedure, and there was no evidence of residual mitral stenosis (Fig. 3, Online Video 2) . Transcatheter VIV implantation within a failed mitral prosthetic valve has been described as feasible and reproducible via the apical approach (1). Here, we present the first such case to our knowledge performed in the United States in an elderly woman not amenable to redo surgical MVR. 
